Listing on duty, Japanese medicine representatives are about to start!

On October 26th, the Japan Pharmaceutical Representative Certification Center published the Outline of Certification of Pharmaceutical Representatives, the first of which states that, as an "expert", the pharmaceutical representative, with patients as the center, carried out the information activities necessary for the rational use of drugs, and continuously improved his qualifications in his career, thus contributing to people's health and health conditions.
's new Platform makes it clear that pharmaceutical representatives are "experts" in the information activities necessary for the rational use of medicines, and that medical representatives must then wear a "medical representative badge" for their activities, and that the new certification system will take effect on April 1, 2021.
the news came out, just one day later, on mercari, a japanese second-hand trading website, the Japanese medicine representative certification badge had been sold out, with a transaction price of 6,000 to 7,500 yen, and another 8,000 yen hung up at night.
According to Dami understand that the Japanese medicine representative has the badge from 2008, when the Japanese medicine representative certification center was established 10 years, but basically no representative to wear this, the system does not require is the main reason, of course, many people feel that the style is also a bit ugly.
Last year, Japan had the voice that pharmaceutical representatives had to wear an "MR badge" for their activities, which was previously shared by Dmi, and on April 8, 2019, the Japan Medical Representative Certification Center released the report of the Business Structural Reform Symposium, which has been studying fundamental changes to the certification system for pharmaceutical representatives. As a result of this discussion by the
Research Council, it is hoped that pharmaceutical companies will make improving MR qualification an important business strategy, and that the reform will focus on MR's "continuing education" to "cultivate MR that promotes patient-centered medical services", and that MR will have a sense of mission, and that mr.
according to the current year's revised plan, progress is like this, with public recommendations solicited in April-May 2019, changes applied to the Cabinet Office in October 2020 and the new system implemented in April 2021. in an update released yesterday,
removed the word "universality" from the definition of pharmaceutical representative, clearly ingesting that pharmaceutical representative is "contributing to the correct use of medicines and the improvement of treatment programmes", which is said to be easily misread as an attempt to increase sales, as medical technology has soared Development, innovative drugs continue to be on the market, all parties hope that pharmaceutical representatives can contribute to this change, at the same time, in the new outline of the seminar, medical institutions also put forward, "in order to improve their own level of medical technology, we must know how to use drugs" and other opinions, therefore, "hope that pharmaceutical representatives can contribute to the improvement of medical technology" was included in the outline.
, as a tool for information exchange, activities such as the use of "digital tools" have been included in addition to traditional face-to-face visits.
For the qualification of medical representatives, the education certification requirements of medical representatives so far are, "must have the necessary knowledge, skills and ethics of medical representative activities", according to the head of the Japan Medical Representative Certification Center, medical representatives can not rely on the trust of medical personnel alone, but also must have the ethics that can win the trust of patients and the general public, to increase the trust of patients and the general public, "as a partner of medical personnel, to stand in the position of contributing to patients.
's new outline states that "medical representatives have great ambitions and a sense of mission, and in order to carry out patient-centered activities, they must wear a medical representative badge when carrying out medical representative activities", as mentioned earlier, the new requirements will be formally implemented on April 1 next year, which means that Japanese pharmaceutical representatives will be licensed to take up their posts in the future.